Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients
Top Cited Papers
Open Access
- 24 October 2014
- journal article
- research article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 100 (1), 107-113
- https://doi.org/10.3324/haematol.2014.107714
Abstract
Infections are a major cause of morbidity and mortality in patients with multiple myeloma. To estimate the risk of bacterial and viral infections in multiple myeloma patients, we used population-based data from Sweden to identify all multiple myeloma patients (n=9 253) diagnosed from 1988 to 2004 with follow-up to 2007 and 34 931 matched controls. Cox proportional hazard models were used to estimate the risk of infections. Overall, multiple myeloma patients had a 7-fold (hazard ratio =7.1; 95% confidence interval = 6.8-7.4) risk of developing any infection compared to matched controls. The increased risk of developing a bacterial infection was 7-fold (7.1; 6.8-7.4), and for viral infections 10-fold (10.0; 8.9-11.4). Multiple myeloma patients diagnosed in the more recent calendar periods had significantly higher risk of infections compared to controls (p<0.001). At one year of follow-up, infection was the underlying cause in 22% of deaths in multiple myeloma patients. Mortality due to infections remained constant during the study period. Our findings confirm that infections represent a major threat to multiple myeloma patients. The effect on infectious complications due to novel drugs introduced in the treatment of multiple myeloma needs to be established and trials on prophylactic measures are needed.Keywords
This publication has 30 references indexed in Scilit:
- Patterns of Improved Survival in Patients With Multiple Myeloma in the Twenty-First Century: A Population-Based StudyJournal of Clinical Oncology, 2010
- Infections in Patients with Multiple Myeloma in the Era of High‐Dose Therapy and Novel AgentsClinical Infectious Diseases, 2009
- Analysis of Herpes Zoster Events Among Bortezomib-Treated Patients in the Phase III APEX StudyJournal of Clinical Oncology, 2008
- Cyclophosphamide plus dexamethasone is an efficient initial treatment before high‐dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myelomaCancer, 2007
- Immunodeficiency and immunotherapy in multiple myelomaBritish Journal of Haematology, 2007
- Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964–2003International Journal of Cancer, 2007
- Patterns of Survival in Multiple Myeloma: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2003Journal of Clinical Oncology, 2007
- Major Complications following Hematopoietic Stem Cell TransplantationSeminars in Respiratory and Critical Care Medicine, 2006
- Early Mortality After Diagnosis of Multiple Myeloma: Analysis of Patients Entered Onto the United Kingdom Medical Research Council Trials Between 1980 and 2002—Medical Research Council Adult Leukaemia Working PartyJournal of Clinical Oncology, 2005
- The risk of bacteremia in patients with monoclonal gammopathy of undetermined significanceEuropean Journal of Haematology, 1998